Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001645470-20-000002
Filing Date
2020-01-24
Accepted
2020-01-24 11:56:57
Documents
1
Period of Report
2019-12-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 12201
  Complete submission text file 0001645470-20-000002.txt   13836
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Issuer) CIK: 0001528172 (see all company filings)

EIN.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address
Collier Alan Brian (Reporting) CIK: 0001645470 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-55453 | Film No.: 20544425